| FOHFX | FOITX | FOHFX / FOITX | |
| Total Expense Ratio | 0.46 | 1.20 | 38% |
| Annual Report Gross Expense Ratio | 0.46 | 1.20 | 38% |
| Fund Existence | 41 years | 31 years | - |
| Gain YTD | 1.344 | 1.493 | 90% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 515M | 899M | 57% |
| Annual Yield % from dividends | 2.81 | 2.90 | 97% |
| Returns for 1 year | 6.76 | 6.75 | 100% |
| Returns for 3 years | 12.25 | 9.96 | 123% |
| Returns for 5 years | 4.22 | -3.74 | -113% |
| Returns for 10 years | 17.97 | 0.21 | 8,554% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SBTU | 2.05 | 0.07 | +3.54% |
| T-REX 2X Long SBET Daily Target ETF | |||
| ILCV | 101.92 | 0.70 | +0.69% |
| iShares Morningstar Value ETF | |||
| TPIF | 37.46 | 0.09 | +0.24% |
| Timothy Plan International ETF | |||
| FTXH | 36.02 | -0.08 | -0.21% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| RDYY | 19.70 | -1.10 | -5.30% |
| YieldMax RDDT Option Income Strategy ETF | |||